基于预后营养指数的小细胞肺癌免疫疗法
Xinling Zhang1, Yaxuan Zhang1, Jiaqi Zhang1
1Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
Frontiers in immunology
|June 10, 2025
概括
预后营养指数 (PNI) 对小细胞肺癌 (SCLC) 治疗至关重要. 低PNI表明预后不佳,这表明PNI指导的饮食治疗可以提高SCLC患者的免疫治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 营养科学 营养科学
背景情况:
- 基于的化疗是小细胞肺癌 (SCLC) 的标准治疗方法,但其疗效低于最佳.
- 患者的营养状况和瘤微环境显著影响SCLC的预防和治疗.
- 营养不良与免疫疗法耐受性差,生活质量降低以及癌症患者的生存率降低有关.
研究的目的:
- 研究预后营养指数 (PNI) 在SCLC免疫治疗中的作用和影响.
- 探索PNI指导的SCLC患者饮食治疗的潜力.
- 建立PNI作为全面SCLC免疫治疗的新策略.
主要方法:
- 审查关于PNI,SCLC和免疫治疗的现有文献.
- 分析PNI作为肺癌和SCLC的预后因素.
- 探索PNI与SCLC治疗结果之间的关系.
主要成果:
- 低预后营养指数 (PNI) 是一种独立的预后因素,与包括肺癌在内的各种癌症的生存率降低有关.
- 在SCLC患者中,PNI预测了长期结果和短期并发症.
- 在SCLC免疫治疗中PNI的作用需要进一步的系统共识.
结论:
- 在SCLC患者中,PNI是预后和治疗反应的重要指标.
- 由PNI指导的饮食干预可以改善免疫疗法的疗效和SCLC患者的治疗结果.
- PNI代表了对综合性SCLC免疫疗法的有前途的新策略.
相关概念视频
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


